Pulmonology

Tarlatamab: A New Standard for Small-Cell Lung Cancer

Introduction Small-cell lung cancer (SCLC) is one of the most aggressive and difficult-to-treat forms of cancer, characterized by rapid growth and early metastasis. For decades, patients who progressed after initial platinum-based chemotherapy faced poor prognoses and limited treatment options, often relying on older chemotherapy agents with modest efficacy and high toxicity. This landscape shifted significantly on November 19, 2025, when the U.S. Food and Drug Administration

Fay

Feb 23 min read

Asthma Explained: How Your Immune System Shapes Your Breathing

A Vulnerable Airway Lining: Where Asthma Begins Asthma begins in the thin lining of the airways, which normally acts like a protective shield against allergens, pollution, smoke, and other irritants. In people with asthma, this protective layer becomes weakened and “leaky.” The tiny connections between airway cells loosen, allowing irritants to slip through more easily. When this happens, the airway lining sends out distress signals -called alarmins- that alert the immune sy

Ariel Berger

Dec 28, 20253 min read

Pulmonary Hypertension: Lungs Under Pressure

What is Pulmonary Hypertension? Pulmonary Hypertension (PH) is a disease in which the blood vessels connecting the heart and the lungs develop high blood pressure. This can lead to fluid congestion in the lungs and dysfunction of the right side of the heart, known as Right Heart Failure. Symptoms of Pulmonary Hypertension Symptoms of PH vary from person to person, but commonly include the following: Shortness of Breath (worse with exercise or lying flat) Fatigue Dizziness/lig

Abby Newberry

Dec 27, 20257 min read

When the Air Turns Toxic: The Rising Toll of Wildfire Smoke on Global Health

In recent years, the world has watched skies turn orange from California to Canada, Australia to Greece. The smell of burning forests, once a distant problem, now drifts into cities thousands of miles from the flames. Wildfire smoke has become one of the most visible and dangerous signs of a warming planet and it’s reshaping the way we think about air, health, and preparedness. A Growing Global Threat Wildfires are not new, but their frequency, size, and intensity have increa

Nicole Winship

Dec 11, 20254 min read

Pulmonary Failure : What is it ? Why is it so dangerous ?

Pulmonary Failure Pulmonary failure (respiratory failure) happens when the lungs cannot provide sufficient oxygen to the body or cannot remove carbon dioxide properly . This can lead to serious complications if let untreated including brain damage , organ failure and even death . Due to this pulmonary failure is considered a medical emergency . How does Pulmonary Failure develop ? Pulmonary failure can develop due to many different illnesses or injuries such as: Severe lun

krishgupta0907

Dec 1, 20252 min read

Understanding Cystic Fibrosis: From biology to diagnosis and treatment

Did you know cystic fibrosis was first discovered in the pancreas? In 1938 Dr. Dorothy Anderson, an American pathologist coined the term “cystic fibrosis of the pancreas” based on autopsies of children dying of malnutrition, due to failure of the pancreas. The children in those days did not survive long enough to develop lung disease. What is Cystic Fibrosis (CF)? Cystic fibrosis is a genetic disorder caused by mutation in the gene that codes for the cystic fibrosis trans

Deepti Kumar

Nov 25, 20253 min read

Pulmonary Arterial Hypertension. Credit: Johnson&Johnson

What is Pulmonary Arterial Hypertension?

Pulmonary Arterial Hypertension (PAH) is a rare condition characterized by high blood pressure in the pulmonary arteries. The pulmonary arteries are the blood vessels that carry blood from the right side of the heart to the lungs. The increased blood pressure can cause blood to back up in the right side of the heart. The right ventricle stretches like a water balloon, crowding out the left ventricle, making that smaller and less effective at pumping blood. A backup of blood

Ishaan Bhaduri

Nov 22, 20253 min read

Antibody-Drug Conjugates in Lung Cancer

Introduction Antibody-drug conjugates (ADCs) are emerging as the fastest-growing class of novel drugs in oncology. While the concept itself is not new, they are gradually reshaping the landscape of cancer treatment. For lung cancer, the therapeutic landscape has undergone a dramatic transformation over the past decade—evolving from chemotherapy alone to the addition of targeted therapies and immunotherapies. Now, ADCs are also becoming a significant new option for lung cancer

Fay

Nov 15, 20256 min read